About Boiron Laboratories Private Limited
Data last updated:
Boiron Laboratories Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Boiron Sa. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 December 2015.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2015FTC271266. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹37.7 Cr and a paid-up capital of ₹37.7 Cr. It is led by directors including Prashant Surana (Managing Director) and Prajakta Avil Menezes (Irp/Rp/Liquidator).
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at A – 502 Cello Triumph I. B. Patel Road Goregaon (East), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.92 Cr, a decline of 57% compared to the previous year. For the same year it recorded a net loss of ₹8.17 Cr (net margin -426.3%) and EBITDA of -₹8.16 Cr (EBITDA margin -426%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 22% over five years.
The company is associated with 1 brand: Boiron. The company has 2 deals on record (2 rights issues); the latest was in February 2022. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is Kansas Drugs & Pharmaceuticals Pvt.Ltd. with revenue of ₹4.43 Cr.
The last known website on record is boiron.in.
Company details
Contact details
Boiron Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is boiron.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 502 Cello Triumph I. B. Patel Road Goregaon (East), Mumbai, Maharashtra, India – 400063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Boiron Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Boiron Laboratories is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Boiron Laboratories Private Limited, buy the company report.
Financials of Boiron Laboratories Private Limited
FY 2023 filings availableBoiron Laboratories Private Limited reported revenue of ₹1.92 Cr (down 57% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 57% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.92 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8.16 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.17 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -426% | ||||
| Net Profit Margin | -426.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Boiron Laboratories Private Limited, buy the company report.
Board of directors of Boiron Laboratories Private Limited
Boiron Laboratories has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Surana | Managing Director | 22 Dec 2015 | 10 Years 10 Months | As last reported |
| Prajakta Avil Menezes Also directs: Aegis Resolution Services Private Limited | Irp/Rp/Liquidator | 14 May 2024 | 2 Years 5 Months | As last reported |
| Charles Jean Hugues Deydier | Director | 22 Dec 2015 | 10 Years 10 Months | As last reported |
| Yves Georges Jean Marie Groult | Director | 12 Oct 2018 | 8 Years 0 Months | As last reported |
Peer comparison
Boiron Laboratories Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kansas Drugs & Pharmaceuticals Pvt.Ltd. | ₹4.43 Cr (FY 2023) | 11.0% | Kolkata, West Bengal, India | |||
| Kountry Pharmacare Private Limited | ₹4.43 Cr (FY 2025) | 574.0% | Meerut, Uttar Pradesh, India | |||
| Skysun Lifesciences Private Limited | ₹4.43 Cr (FY 2024) | 29.0% | Ahmedabad, Gujarat, India | |||
| Zing Lifecare Private Limited | ₹4.4 Cr (FY 2025) | -33.0% | Panchkula, Haryana, India | |||
| Intellify Health Private Limited | ₹4.39 Cr (FY 2025) | 141.0% | Aurangabad, Maharashtra, India | |||
| Boiron Laboratories Private Limitedthis company | ₹1.92 Cr (FY 2023) | -₹8.17 Cr | -426.3% | -57.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Boiron Laboratories Private Limited, buy the company report.
Auditor
Boiron Laboratories Private Limited is audited by Kalyaniwalla & Mistry for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kalyaniwalla & Mistry | FY 2023 | 104607W/W100166 |
Shareholding
The shareholding of Boiron Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Boiron Laboratories Private Limited, buy the company report.
Deals & funding
Boiron Laboratories Private Limited has 2 deals on record (2 rights issues); the latest was in February 2022.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2022 | Rights issue | ₹6.7 Cr | Investors: Boiron SA, Boiron Sa & Rajat Mukherje |
| Feb 2019 | Rights issue | ₹16 Cr | Investors: Boiron SA |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Boiron Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Boiron Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Boiron Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Boiron Laboratories Private Limited, buy the company report.
Recent activity
Boiron Laboratories Private Limited has 7 board changes on record since 2015: 4 appointments and 3 cessations. The latest: Prajakta Avil Menezes was appointed as Irp/Rp/Liquidator on 14 May 2024.
Frequently asked questions
Boiron Laboratories is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Boiron Laboratories is a company under liquidation, formerly operating as a foreign private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 December 2015 and is registered under CIN U74999MH2015FTC271266. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Boiron Laboratories has 4 current directors:
- Prashant Surana - Managing Director
- Charles Jean Hugues Deydier - Director
- Yves Georges Jean Marie Groult - Director
- Prajakta Avil Menezes - Irp/Rp/Liquidator
The latest financial statements of Boiron Laboratories on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Boiron Laboratories is U74999MH2015FTC271266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Boiron Laboratories was incorporated on 22 December 2015. It is registered with the Registrar of Companies, Mumbai.
Boiron Laboratories has 2 deals on record (2 rights issues); the latest was in February 2022.
The peers of Boiron Laboratories by revenue are Kansas Drugs & Pharmaceuticals Pvt.Ltd, Kountry Pharmacare Private Limited, Skysun Lifesciences Private Limited, Zing Lifecare Private Limited, Intellify Health Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Prajakta Avil Menezes was appointed as Irp/Rp/Liquidator on 14 May 2024. Yves Georges Jean Marie Groult ceased to be Additional Director on 30 Dec 2019. Yves Georges Jean Marie Groult was appointed as Director on 12 Oct 2018. Boiron Laboratories has 7 board changes on record in total.
Boiron Laboratories can be reached through the website boiron.in. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Boiron Laboratories is at A – 502 Cello Triumph I. B. Patel Road Goregaon East, Mumbai, Maharashtra, India – 400063.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
